A Study of YL-17231 in Patients With Advanced Solid Tumors

NCT06078800 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: YL-17231

Sponsor

Shanghai YingLi Pharmaceutical Co. Ltd.